Notes / Company Shree Ganesh Remedies Ltd. SGRL BSE 540737 ISIN INE414Y01015 Pharmaceuticals Fundamentals Market cap₹802 cr P/E45.18× ROE15.89% Debt / equity0.26 52-week range 381.10 — 640.00 Research on Tijori Finance The timeline — 1 note on Shree Ganesh Remedies Ltd. May 2026 20 May 26 · 20:21 IST Brief Brief · Earnings Shree Ganesh Remedies' Q4 call transcript: already old news The transcript of the May 15 earnings call is now on record, but every material update was already disclosed in the prior concall summary. A routine filing. Verify on exchange BSE filings for SGRL NSE filings for SGRL Tijori Finance company page